Effects of some isoquinoline compounds and certain derivatives on brain phosphodiesterase activity.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001921:Brain / Q000201:enzymology* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D004789:Enzyme Activation / Q000187:drug effects; D006168:Guinea Pigs; D006868:Hydrolysis; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology; D010710:Phosphates / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology
D001593:Benzyl Compounds; D007546:Isoquinolines; D010710:Phosphates; D010726:Phosphodiesterase Inhibitors; D011725:Pyridines; D011743:Pyrimidines; D010208:Papaverine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases